Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Time to onset of efficacy in fracture reduction with current anti-osteoporosis treatments.

Inderjeeth CA, Chan K, Kwan K, Lai M.

J Bone Miner Metab. 2012 Sep;30(5):493-503. doi: 10.1007/s00774-012-0349-1. Epub 2012 May 29. Review.

PMID:
22643863
2.

The effects of an antiosteoporosis herbal formula containing epimedii herba, ligustri lucidi fructus and psoraleae fructus on density and structure of rat long bones under tail-suspension, and its mechanisms of action.

Siu WS, Wong HL, Lau CP, Shum WT, Wong CW, Gao S, Fung KP, Lau CB, Hung LK, Ko CH, Leung PC.

Phytother Res. 2013 Apr;27(4):484-92. doi: 10.1002/ptr.4743. Epub 2012 May 25.

PMID:
22628292
3.

An innovative herbal product for the prevention of osteoporosis.

Leung PC, Cheng KF, Chan YH.

Chin J Integr Med. 2011 Oct;17(10):744-9. doi: 10.1007/s11655-011-0876-y. Epub 2011 Nov 19.

PMID:
22101698
4.

The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women.

Hopkins RB, Goeree R, Pullenayegum E, Adachi JD, Papaioannou A, Xie F, Thabane L.

BMC Musculoskelet Disord. 2011 Sep 26;12:209. doi: 10.1186/1471-2474-12-209. Review.

5.

Physiology of the aging bone and mechanisms of action of bisphosphonates.

Dominguez LJ, Di Bella G, Belvedere M, Barbagallo M.

Biogerontology. 2011 Oct;12(5):397-408. doi: 10.1007/s10522-011-9344-5. Epub 2011 Jun 22. Review.

PMID:
21695491
6.

A review of osteoporosis diagnosis and treatment options in new and recently updated guidelines on case finding around the world.

Leslie WD, Schousboe JT.

Curr Osteoporos Rep. 2011 Sep;9(3):129-40. doi: 10.1007/s11914-011-0060-5. Review.

PMID:
21655931
7.

Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells.

Mok SK, Chen WF, Lai WP, Leung PC, Wang XL, Yao XS, Wong MS.

Br J Pharmacol. 2010 Feb;159(4):939-49. doi: 10.1111/j.1476-5381.2009.00593.x. Epub 2010 Jan 27.

8.

Ultra-short echo-time MRI detects changes in bone mineralization and water content in OVX rat bone in response to alendronate treatment.

Anumula S, Wehrli SL, Magland J, Wright AC, Wehrli FW.

Bone. 2010 May;46(5):1391-9. doi: 10.1016/j.bone.2010.01.372. Epub 2010 Jan 21.

9.

Icariin: a potential osteoinductive compound for bone tissue engineering.

Zhao J, Ohba S, Komiyama Y, Shinkai M, Chung UI, Nagamune T.

Tissue Eng Part A. 2010 Jan;16(1):233-43. doi: 10.1089/ten.TEA.2009.0165.

PMID:
19698057
10.

Effects of tea catechins, epigallocatechin, gallocatechin, and gallocatechin gallate, on bone metabolism.

Ko CH, Lau KM, Choy WY, Leung PC.

J Agric Food Chem. 2009 Aug 26;57(16):7293-7. doi: 10.1021/jf901545u.

PMID:
19653629
11.

Estrogen regulation of apoptosis in osteoblasts.

Bradford PG, Gerace KV, Roland RL, Chrzan BG.

Physiol Behav. 2010 Feb 9;99(2):181-5. doi: 10.1016/j.physbeh.2009.04.025. Epub 2009 May 5.

12.

Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.

Lim LS, Hoeksema LJ, Sherin K; ACPM Prevention Practice Committee.

Am J Prev Med. 2009 Apr;36(4):366-75. doi: 10.1016/j.amepre.2009.01.013. Review.

PMID:
19285200
13.

Impact of osteoporosis treatment adherence on fracture rates in North America and Europe.

Siris ES, Selby PL, Saag KG, Borgström F, Herings RM, Silverman SL.

Am J Med. 2009 Feb;122(2 Suppl):S3-13. doi: 10.1016/j.amjmed.2008.12.002. Review.

PMID:
19187810
14.

Osteonecrosis of the jaws and bisphosphonates.

Pendrys DG, Silverman SL.

Curr Osteoporos Rep. 2008 Mar;6(1):31-8. Review.

PMID:
18430398
15.

Dosing effects of an antiosteoporosis herbal formula--a preclinical investigation using a rat model.

Sun Y, Lee SM, Wong YM, Lau CP, Shaw PC, Qin L, Leung PC, Fung KP.

Phytother Res. 2008 Feb;22(2):267-73.

PMID:
17726734
16.

Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.

Michael H, Härkönen PL, Kangas L, Väänänen HK, Hentunen TA.

Br J Pharmacol. 2007 Jun;151(3):384-95. Epub 2007 Apr 10.

17.

Epidemiology of osteoporosis.

Dennison E, Mohamed MA, Cooper C.

Rheum Dis Clin North Am. 2006 Nov;32(4):617-29. Review.

PMID:
17288968
18.

How long should patients take medications for postmenopausal osteoporosis?

Briot K, Trémollières F, Thomas T, Roux C; Comité scientifique du GRIO.

Joint Bone Spine. 2007 Jan;74(1):24-31. Epub 2006 Dec 4. Review.

PMID:
17223374
19.

Direct and indirect estrogen actions on osteoblasts and osteoclasts.

Zallone A.

Ann N Y Acad Sci. 2006 Apr;1068:173-9. Review.

PMID:
16831916
20.

Supplemental Content

Support Center